GT Apeiron Therapeutics Company
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.
Technology:
Biotechnology, Health Care, Therapeutics
Industry:
Early Drug Development
Headquarters:
Shanghai, Shanghai, China
Founded Date:
2019-01-01
Employees Number:
11-50
Funding Status:
Venture - Series Unknown
Investors Number:
1
Total Funding:
27000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-06-11
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership